Preparation and characterization of the first coordination compounds of tetrazol-2-ylacetic acid
摘要:
Tetrazol-2-ylacetic acid (2-TzaH) was found to react with CuCl2, PdCl2, and K2PtCl4 in water giving Cu(2-Tza)(2), PdCl2(2-TzaH)(2)center dot 2H(2)O and PtCl2(2-TzaH)(2), correspondingly. Obtained complexes, being the first reported examples of coordination compounds derived from 2-TzaH, have been characterized by IR spectroscopy, thermal and X-ray diffraction methods. 2-TzaH was found to act as a monodentate ligand coordinated to the metal ion via N4 atom of heteroring in palladium complex and as tridentate bridging ligand coordinated via N4 atom and two oxygen atoms in copper complex. Cu(2-Tza)(2) presents 2D coordination polymer, whereas PdCl2(2-TzaH)(2)center dot 2H(2)O is molecular complex. (C) 2010 Elsevier B.V. All rights reserved.
[EN] 7-OXO -6-(SULFOOXY)- 1,6-DIAZABICYCLO [3.2.1] OCTANE CONTAINING COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] 7-OXO-6-(SULFOOXY)-1,6-DIAZABICYCLO[3.2.1] OCTANE CONTENANT DES COMPOSÉS ET LEUR UTILISATION DANS LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
申请人:WOCKHARDT LTD
公开号:WO2017081615A1
公开(公告)日:2017-05-18
Compounds of Formula (I) or a stereoisomer or a pharmaceutically acceptable salt thereof, their preparation, and use in treating a bacterial infection are disclosed.
化合物的公式(I)或其立体异构体或药学上可接受的盐,其制备以及在治疗细菌感染中的用途被披露。
ARYL DIHYDROPYRIDINONE AND PIPERIDINONE MGAT2 INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:US20130143843A1
公开(公告)日:2013-06-06
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
Aryl dihydropyridinone and piperidinone MGAT2 inhibitors
申请人:Bristol-Myers Squibb Company
公开号:US08791091B2
公开(公告)日:2014-07-29
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:US20150315144A1
公开(公告)日:2015-11-05
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.